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Highlights:  
• SMIs are potentially effective after primary treatment for breast cancer, although 
effect sizes are small and inconsistent across HRQoL domains. 
• SMIs predominantly promote recipients’ physical and functional well-being, 
regardless of self-management skills applied. 
• SMIs are mainly prescribed for 12 weeks, but optimal dosage cannot be confirmed 
currently.  
• SMIs informed by CBT and/or offered through recipient education seem to be 
marginally more effective. 
 
Abstract 
Purpose: Self-management interventions (SMIs) are designed to empower people living 
beyond breast cancer and help them adjust to a new normal. This structured review aimed to 
critically appraise and synthesise up-to-date evidence on the effectiveness of SMIs to 
promote health-related quality of life (HRQoL) in people with breast cancer in the post-
treatment period.  
Methods: According to PRISMA statement guidelines, MEDLINE, EMBASE and CINAHL 
were searched for peer-reviewed publications of randomised controlled trials of SMIs. Pre-
specified selection criteria were applied to all retrieved records. Methodological quality and 
risk of bias were evaluated by using the Caldwell framework and Cochrane Collaboration 
Risk of Bias tool, respectively. Findings were integrated into a narrative critical evidence 
synthesis. 
Results: Nine eligible trials were identified that tested nine SMIs. Five SMIs were based on 
cognitive behaviour therapy (CBT). Eight SMIs targeted recipients’ decision-making and 
taking-action skills. Across trials, gains in one to four domains of HRQoL were reported. 
SMIs predominantly promoted recipients’ physical and functional well-being, regardless of 
methodological quality or self-management skills applied, but effect sizes were consistently 
small. SMIs were mainly prescribed for 12 weeks, but optimal dosage cannot be confirmed 
currently. SMIs informed by CBT and/or offered through recipient education were marginally 
more effective. Evidence derived from moderate-to-good quality trials.  
Conclusions: SMIs are potentially effective after primary treatment for breast cancer, 
although effect sizes are small and inconsistent across HRQoL domains. More rigorous 
development and testing is required, while co-production from the early development stages 
or at the refinement phase is recommended.  
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As a result of advances in early detection and treatment of breast cancer, a rising number of 
women and men will transit from being ‘patients’ to living beyond breast cancer (Harrow et 
al., 2014; Siegel et al., 2015). Completion of cancer treatment does not mean the end of the 
cancer experience. Variable deficits in health-related quality of life (HRQoL) might be 
experienced during treatment and carried over to the post-treatment period (Trusson, 2014). 
Such deficits might be difficult to turn around even a year post-treatment (Lee et al. 2011). 
Physical well-being can be influenced by lymphoedema, fatigue and sleep disorders, which 
restrict the ability to perform a series of daily tasks; anxiety and distress can reduce 
psychological well-being and put strains on family relations and social networks, which is a 
potential threat for social well-being (Ewertz and Jensen, 2011). Often, traditional medical 
follow-ups fail to meet people’s post-treatment and medium-to-long-term supportive care 
needs. People living beyond breast cancer must be supported to develop the skills and 
confidence to monitor and manage their own health (Phillips and Currow, 2010) in addition 
or in conjunction to routine follow-up and potential survivorship care plans. Changing the 
emphasis of current follow-up from disease-monitoring to a more comprehensive model of 
aftercare is thus required (Eccles et al., 2013). 
Enabling supported self-management in cancer care requires considerable effort and 
organisational changes, but promises to offer better disease and symptom control, smoother 
adjustment to life beyond cancer, and a model of care that is more streamlined to people’s 
needs if and when these occur (Boger et al., 2015). Self-management interventions (SMIs) 
promise to offer ongoing and structured support to people living beyond cancer (Lorig and 
Holman, 2003). SMIs act as coaching means to provide the skills necessary to help people 
actively identify and effectively report challenges or even solve problems (Boger et al., 
2015). In turn, SMIs can bring about modest improvements in self-efficacy, mood, physical 
symptoms and health service utilisation (Boger et al., 2015). SMIs typically incorporate five 
core skills: problem solving, decision making, resource utilisation, forming of a patient-
healthcare provider partnership, and taking-action (Lorig and Holman, 2003). As such, SMIs 
have gradually come to be considered a key part of post-treatment, mainly because people 
are increasingly expected to assume responsibility to monitor their own health at home 
(Grady and Gough, 2014).  
Diverse modes of delivery have been implemented to support testing the various SMIs in 
cancer care. To date, literature reviews in this area have either focused on one type of SMI 
or have only reviewed the effectiveness of one domain of HRQoL. Cheng et al. (2017) only 
reviewed home-based SMIs; Triberti et al. (2019) only evaluated e-health SMIs; Van Dijck et 
al. (2016) only considered the effects of physical self-management. Moreover, Boland et al. 
(2018) systematically reviewed SMIs regardless of cancer type. Although there are 
commonalities in terms of the impact that different types of cancer have on people, those 
living with and beyond breast cancer likely face unique issues, including sexual dysfunction, 
post-mastectomy/ lumpectomy psychological distress and body image changes, and 
premature aging due to endocrine effects (Fouladi et al., 2018; Stefanic et al., 2014). Such 
adverse experiences might pose a heavier burden compared to other types of cancer. SMIs 
developed for other types of cancer might have limited or unconfirmed application to people 
living beyond breast cancer. Given this knowledge gap, the authors set out to review the 
characteristics and effectiveness of the different SMIs specifically developed for and tested 
with people living beyond breast cancer. The aim of this review was to provide a critical 
synthesis of up-to-date evidence to identify how effective existing SMIs are in promoting 





A structured review was conducted in line with the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA) statement (Moher et al., 2009).  
2.1 Research question formation  
To formulate the research question, the ‘population, intervention, comparison, outcomes’ 
(PICO) typology (Santos et al., 2007) was used. The PICO components considered are 
outlined below:  
• Population: Adult men and women, diagnosed with eary-stage breast cancer and post-
completion of primary treatment (surgery, chemotherapy or radiotherapy). 
• Intervention: Different types of SMIs and different modes of delivery such as e-health, 
education or home-based practice. 
• Comparison: Usual/standard care plans including wait list controls.  
• Outcomes: Metrics of overall HRQoL and individual domains of well-being in the form of 
total and subscale scores derived from self-reported questionnaires. 
Based on the above, the research question for this review was: “In adult men and women 
diagnosed with early-stage breast cancer and after completion of primary treatment, what is 
the effectiveness of the different types of SMIs on promoting self-reported HRQoL and well-
being when compared to usual/standard care?" 
2.2 Search strategy 
Three major electronic databases (MEDLINE, EMBASE and CINAHL) were searched, using 
the keywords outlined in Table 1. The reference lists of eligible papers and key relevant 
articles on this topic were also examined for additional eligible studies. Searches were 
initially run in April 2019 and updated them in November 2019. No new eligible articles were 
found during this second iteration. 
2.3 Eligibility criteria 
Eligibility criteria were based on the PICO contents and objectives of this review. Inclusion 
criteria were as follows: 
• People diagnosed with stage I-III breast cancer. As the lived experience of early-stage 
versus metastatic breast cancer can differ considerably (Vondeling et al.,2018), people 
with early-stage breast cancer were specifically targeted to create a more uniform 
sample. 
• Men and women, aged ≥18 years, who had completed primary treatment for breast 
cancer, including surgery, chemotherapy or radiotherapy. According to Morgan (2009), 
‘cancer survivors’ can be defined as those who have experienced cancer and are still 
alive, and this definition includes peoples at the post-treatment period.  
• SMIs developed to promote at least one of participants’/recipients’ core self-
management skill.  
• SMIs tested via a randomised controlled trial (RCT). RCTs are recognised as the ‘gold 
standard’ in evaluating the effectiveness of interventions against a controlled condition 
(Creswell et al., 2009). Waiting list controls were also considered.   
• Metrics of overall HRQoL and domains of well-being (regardless of whether reported as 
primary or secondary outcomes) as measured via self-reported questionnaires with 
proven reliability and validity. Using high-quality, validated questionnaires caters for 
lower risk of measurement bias (El Fakir et al., 2014).  
• Studies published in peer-reviewed journals and in English.  
• Original research articles published within the past 10 years. Processing up-to-date 
evidence would increase the clinical usefulness and relevance of this review. 
Articles were excluded for the following reasons:  
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• Study participants diagnosed with stage IV breast cancer, i.e. with metastatic disease, 
whereby breast cancer cells spread beyond the sentinel nodes of the breast and to 
other distant sites (Berman et al., 2013).  
• Experimental studies without a control group. A control group refers to a group of 
participants whose performance regarding an outcome variable is used to evaluate the 
performance of the experimental group. If an experimental study does not include a 
control group, the risk of bias increases and the confidence in the true effectiveness of 
the intervention is compromised (Creswell et al., 2009). 
• Studies involving samples with mixed cancer diagnoses, unless a separate analysis for 
people with breast cancer was reported. 
• Literature reviews, qualitative studies, case studies commentaries and study protocols. 
2.4 Review process and data extraction 
Following article retrieval and de-duplication, the first author screened the retrieved articles 
for eligibility following a two-stage process. The first stage was to shortlist articles based on 
titles and abstracts. The second stage was the retrieval of potentially relevant articles in full-
text. If studies were excluded after reading the full-texts, the reasons for doing so were 
recorded. Data from the final sample of eligible articles were then extracted. A bespoke 
evidence table was developed for this review to aid in the data extraction. The first author 
extracted all data, which were then double-checked by the second author.  
2.5 Assessment of methodological quality and bias  
The tool designed by Caldwell et al. (2011) was used to evaluate the methodological quality 
of the selected studies. Vader (1998) points out that core elements for assessing the quality 
of an RCT include the intervention design, internal validity, external validity, data analysis 
and ethical issues. This framework covered all these elements with 18 questions, and three 
possible answers for each question (no=0, partly=1, yes=2). Typically, the ‘partly’ score 
means that some information was provided, but only to a limited extent (Caldwell et al., 
2011). The maximum value for each reviewed article was 36; higher scores indicated better 
methodological quality. Although there were no clear score ranges to indicate quality status, 
a score of >30 was considered as indicating methodologically robust studies, while scores 
between 25 and 30 were considered to indicate studies of moderate quality. No studies were 
excluded based on methodological quality. Details about quality assessment for the included 
articles can be found in Supplementary file 1.  
Creswell (2009) points out that unexpected biases can lead to underestimation or 
overestimation of true intervention effects. The Cochrane Collaboration tool developed by 
Julian et al. (2011) was also used to assess the risk of bias in the included RCTs. Six 
domains were evaluated, namely: 1) random sequence generation; 2) allocation 
concealment; 3) blinding of participants/personnel; 4) blinding of outcome assessment; 5) 
incomplete outcome data; 6) selective reporting. The risk of bias for each of these domains 
was determined to be low, high or unclear. ‘Low’ indicates that the risk of bias was 
acceptable, ‘high’ means that the risk of bias was high, and unclear means that there is 
insufficient information to make a judgement.  
2.6 Data analysis synthesis 
A narrative approach to this evidence synthesis was used, also creating thematic summaries 
of findings within similar context (Popay et al., 2006). Popay et al. (2006) point out that 
outcomes synthesised as a narrative are more contextualised and understandable to 
readers. Thematic summaries can offer detailed and focussed descriptions of evidence 
pertinent to specific outcomes within salient themes (Thomas et al., 2012). The thematic 
categories were informed by the different aspects of well-being reported in the reviewed 
articles, i.e. physical, psychological, cognitive, social, functional, and overall HRQoL. 
Moreover, to quantify the magnitude of the reported SMI effects and contextualise their 
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clinical importance, Cohen’s d effect sizes (differences in mean HRQoL scores between 
intervention and control at post-treatment adjusting for baseline scores) were calculated, 
using the online formulae available at https://www.psychometrica.de/effect_size.html. By 
convention, d<0.20 indicated negligible intervention effect; d=0.20-0.49 ‘small’ effect, 
d=0.50-0.79 ‘moderate’ effect, and d≥0.80 ‘large’ effect (Cohen, 1992). For readability 
purposes, references to ‘participants’ indicate participants in both the intervention and 
control groups, while references to ‘recipients’ indicate participants in the intervention group 
only. Moreover, the terms RCT and trial are used interchangeably to refer to the final sample 
of reviewed RCTs. 
 
3. Results 
3.1 Search results 
The initial searches retrieved 503 articles. Once duplicates were removed (n=214), 289 
articles were screened based on title and abstract. Subsequently, full-text versions of 54 
potentially relevant articles were assessed for eligibility. Nine articles that reported on nine 
unique RCTs were included in the final sample (Figure 1). Table 2 outlines the 
methodological characteristics and quality of the selected RCTs.  
3.2. Characteristics of the included RCTs and SMIs  
Trial sample sizes ranged from 42 to 288 participants. The trials were conducted in the USA 
(n=4) and Oceania (n=1), as well as developed countries in Asia (n=2) and Europe (n=2). 
There were eight two-arm trials and one three-arm trial (Zick et al.,2016). Intervention 
duration ranged between 3 and 24 weeks. Admiraal et al. (2017) and Lee et al. (2014) used 
web-based platforms to deliver their interventions.  
Chan et al. (2017) and Beatty et al. (2010) used structured education with group and self-
study respectively, while Kvale et al. (2016) used single coaching sessions. Three SMIs 
employed a combination of two strategies, namely home-based practice with coaching or 
structured education (Lahart et al., 2016, Zick et al., 2016); Hoffman et al., 2012). Rogers et 
al. (2015) used structured education, home-based practice and coaching.  
Three SMIs involved recipient self-study (Admiraal et al. 2017; Lee et al., 2014; Beatty et al., 
2010); health care providers delivered the SMIs in the rest of reviewed RCTs. Five SMIs 
applied cognitive behaviour therapy (CBT) (Westbrook et al., 2016) as the foundation of the 
training (Chan et al., 2017; Hoffman et al., 2012; Roger et al., 2015; Lahart et al., 2016; 
Beatty et al., 2010). 
3.3 Psychometric robustness of the outcome measures  
Four trials used the generic European Organization for Research and Treatment of Cancer 
Quality of Life Questionnaire (EORTC QLQ-C30) as their primary outcome measure 
(Admiraal et al., 2017; Beatty et al., 2010; Chan et al., 2017; Lee et al., 2014). Zick et al. 
(2016) and Kvale et al. (2016) used the Long-Term Quality of Life Instrument (LTQL) and the 
36-Item Short Form Health Survey (SF-36), respectively.  
Only three trials used a breast-cancer-specific Functional Assessment of Cancer Therapy-
Breast (FACT-Breast) outcome measure (Hoffman et al., 2012; Rogers et al., 2015; Lahart 
et al., 2016). All outcome measures met the minimal standards for internal consistency 
(Cronbach’s alpha coefficient ≥0.70), as well as content and construct validity (Aaronson et 
al., 1993; Hahn et al., 2015; Wyatt et al., 1996; Ware et al., 1998). 
3.4 Risk of bias in the RCTs  
Risk of bias evaluation is detailed in Table 2. Randomisation was conducted using a 
computer-generated randomisation list in all trials. Eight trials concealed the allocation 
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sequence until intervention began; Kvale et al. (2016) did not clarify whether allocation had 
been concealed. Absence of double-blinding and inadequate concealment of allocation 
effects may exert an influence according to the expectations of participants or clinicians 
(Creswell, 2009). Due to the unique nature of the SMIs, double-blinding was not practically 
feasible as participants could well guess the treatment allocation. The use of self-reported 
measures of HRQoL likely alleviated the effects of this type of bias as researchers did not 
interfere with participants’ reporting during data collection.  
Six trials employed an intention-to-treat analysis. Beatty et al. (2010) and Kvale et al. (2016) 
used linear mixed modelling and Admiraal et al. (2017) used multiple imputation analysis. 
These methods ensured that, despite participant withdrawal and missing data, all available 
research data were included in the final analysis to avoid overoptimistic estimates of the 
efficacy of the intervention (Galbraith et al., 2017; Gupta 2011; Van Buuren, 2007). In Lee et 
al. (2014), only two women missed the follow-up; because missing data were well-balanced 
between intervention and control group, it is unlikely that attrition biased findings of this trial. 
One trial was evaluated as high risk for selective reporting bias due to the results being 
contrary to expectations (Admiraal et al., 2017). All trials complied with CONSORT 
guidelines (Begg et al., 1996; Schulz et al., 2010). The CONSORT urges completeness, 
clarity and transparency in reporting for RCT, which reflects the actual trial design and 
conduct (Schulz et al. 2010). 
Sample sizes were informed by formal, a priori power calculation in all trials but Kvale et al. 
(2016). Where no justification was provided for the choice of sample size, the risk of missing 
an important intervention effect due to limited power increases (Creswell, 2009). No ad hoc 
power calculation was reported for any trial. Another potential bias was the use of 
convenient sampling in all trials, which may pose a threat to the internal validity of an RCT 
(Creswell 2009). Finally, although SMIs in Admiraal et al. (2017) and Lee et al. (2014) were 
web-based, internet access could be a restriction for specific population sub-groups, such as 
older people and those with low technology literacy and/or low income, thus impacting on the 
representativeness of the sample.  
3.5 Overall methodological quality of the RCTs 
Quality scores using Caldwell et al.’s (2011) framework ranged from 28 to 34 (see Table 2 
and Supplementary file 1). In conjunction to risk of bias evaluation, the overall quality of the 
reviewed trials reveals moderate-to-high methodological quality.  
3.6 Effectiveness of the SMIs 
3.6.1 Physical well-being 
Five in nine trials showed statistically significant effectiveness of SMIs on recipients’ physical 
well-being (Chan et al., 2017; Hoffman et al., 2012; Lee et al., 2014; Rogers et al., 2015; 
Zick et al., 2016); three of these trials were based on CBT. All four trials were 
methodologically robust. Across trials however, effect sizes were negligible-to-small, ranging 
from 0.14 to 0.37 overall, and from 0.19 to 0.37 where statistical significance was also 
confirmed (Table 2). Relaxing acupressure with structured education had the largest effect 
on physical well-being at 6 weeks post-intervention and across trials (d=0.37) (Zick et al., 
2016).  
Chan et al. (2017) – effect size d=0.32 – were the only ones to consider the cultural context 
and lifestyle preferences of SMI recipients, which may have catered for greater acceptability 
of the SMI and easier integration to recipients’ daily activities. Nonetheless, the short time-
frame for intervention delivery (three weeks in Chan et al., 2017) might have prevented from 
larger intervention effects to show. The SMI tested in Kvale et al. (2016) was the only one to 
actively promote a partnership skill with healthcare providers that might have led to a follow-
up more tailored to participants’ physical needs; however, bias interfering with this trial might 
have led to lack of statistical significance and only small intervention effects (d=0.29). 
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3.6.2 Emotional well-being 
Only three trials reported statistically significant improvements in emotional well-being 
(Hoffman et al., 2012; Kvale et al., 2016; Rogers et al. 2015) with only small effect sizes 
(d=0.23-0.32). Two of these trials employed CBT-based SMIs (Hoffman et al., 2012; Rogers 
et al. 2015), although the SMI by Hoffman et al. (2012) was associated with effectiveness of 
greater clinical importance. Hoffman et al. (2012) used a mindfulness-based method to urge 
participants to actively face their current health condition rather than avoid it. The remaining 
six trials yielded no statistically significant results, with negligible effect sizes.  
Although Admiraal et al. (2017) and Chan et al. (2017) did use tailored psychological 
interventions with their participants, these were not linked to statistical significance or clinical 
importance. Ceiling effects at baseline might explain these findings. Several participants in 
Admiraal et al. (2017) reported no major psychological issues for which they needed 
additional support. In sub-group analyses though, the sub-group of distressed patients did 
seem to find greater benefit from the SMI (Admiraal et al., 2017).  
3.6.3 Social well-being 
Two trials reported statistically significant gains in intervention recipients’ social well-being 
(Hoffman et al., 2012; Zick et al., 2016). Effect sizes were negligible (d=0.16-0.19). The rest 
of trials yielded no statistically significant or clinically important findings. Common self-
management skills in Zick et al. (2016) and Hoffman et al. (2012) were decision-making, 
taking action and problem solving. Both SMIs were also delivered using education combined 
with home-based practice, which likely promoted problem-solving skills, helping participants 
to feel in control of issues within their social environment. In both trials, the SMIs were 
associated to significant gains in fatigue management and mood state, which might partially 
explain more positive scores on social well-being. 
3.6.4 Functional well-being 
Eight trials evaluated functional well-being (Table 2); five of them showed statistically 
significant improvement (Hoffman et al., 2012; Kvale et al., 2016; Lahart et al., 2016; Rogers 
et al., 2015; Zick et al., 2016) with small-to-moderate effect sizes (d=0.28-0.66). Only one 
SMI was associated with moderate effects (d=0.66) on functional well-being (Kvale et al., 
2016).  
There are two key points related to these positive effects. First, decision-making and taking-
action were the two self-management skills that recipients were trained on across the four 
trials. Recipients could choose a suitable exercise level according to their physical situation 
before taking-action to finish the short-term plan. Second, in Rogers et al. (2015) and Lahart 
et al. (2016), SMIs focused on physical deficits, which might have helped in the management 
of breast cancer-specific symptoms to allow recipients to perform the usual tasks of daily 
living and carry out social roles. No trial specifically considered age-related implications 
when evaluating the recipients’ functional well-being.  
3.6.5 Cognitive well-being 
In four trials, use of the EORTC QLQ-C30 allowed for evaluation of participants’ cognitive 
well-being (Table 2). Only Beatty et al. (2010) reported statistically significant improvement 
associated with a moderate effect size (d=0.59) at 24 weeks post-intervention although no 
intervention effects were found at 12 weeks. Two factors might underpin these positive 
effects. First, delivery of the SMI involved self-study education, which might have promoted 
recipients’ mental acuity. Second, participants had only recently completed treatment 
(previous 3 months), which might allow for any deficits in cognitive well-being to reverse 
more easily.  
3.6.6 Global HRQoL 
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Three trials showed statistically significant improvement of global HRQoL (Hoffman et al., 
2012; Lahart et al., 2016; Rogers et al., 2015); effect sizes were small (d=0.23-0.40). Two 
main factors might have played a role to these positive effects. First, all three trials used 
multiple rather than single intervention delivery modes most commonly education and home-
based practices. Delivery modes were chosen to be relatively brief and highly feasible, thus 
allowing easy practice at home and regular follow-up sessions. Second, all three trials 
targeted their recruitment on a sample size that was based on an a priori power calculation, 
which has likely increased the internal validity of the trial and its ability to detect a true 
difference between the experimental conditions. Of the remaining trials, where overall 
HRQoL scores were calculated, deficits in either or both of the aforementioned aspects 
could feasibly explain lack of statistically significant and/or clinically important findings. 
 
4. Discussion 
4.1 New evidence from this review 
Evidence from the reviewed trials suggests gains in one to four domains of HRQoL of people 
with breast cancer in the post-treatment period. Current evidence on SMI effectiveness is 
nevertheless ambiguous. SMIs seem to predominantly promote recipients’ physical and 
functional well-being, regardless of methodological quality or self-management skills applied. 
Effect sizes in relation to physical and functional well-being are consistently small regardless 
of statistical significance. The magnitude of SMI effects on emotional well-being and overall 
HRQoL is likely larger by a fraction, however only one in three trials reported statistically 
significant findings. The evidence on functional well-being is compromised by a smaller 
number of trials that did evaluate it. Effects on social or cognitive well-being cannot be 
confirmed. Prescription of SMIs for 12 weeks seems a popular choice, but whether it is 
optimal from an intervention effectiveness standpoint it cannot be confirmed currently. SMIs 
informed by CBT and/or offered through recipient education (particularly in combination with 
other training modes) seem to be marginally more effective. 
4.2 Confidence in the evidence 
Potential reasons affecting one’s confidence in the available evidence include: (a) wide 
diversity in the tested SMIs in terms of nature, content, duration and delivery; (b) difficulty to 
verify recipient adherence to prescribed SMI; (c) differences in the proportion of older people 
and people with lower educational attainment levels among recruited participants compared 
to the general population of people with breast cancer; (d) unconfirmed feasibility of some of 
the SMIs in the post-treatment period; (e) use of generic rather than breast cancer-specific 
HRQoL tools that might have conflated SMI effects; (f) issues with randomisation and 
blinding that might have interfere with establishment of true SMI effectiveness; (g) evidence 
for some unplanned and therefore likely underpowered secondary analyses of data; (h) 
exclusive focus on women living beyond breast cancer and intervention settings in 
developed countries; and (i) wide variation in the definition of people living beyond cancer 
(referred to as ‘breast cancer survivors’, which might confuse evidence on SMI effectiveness 
due to differences in health status deficits at different time-points. 
4.3 CBT-informed SMIs 
SMIs informed by CBT seem to be more effective compared to other SMIs. CBT seems able 
to promote any domain of HRQoL regardless of type of SMI, particularly where skills around 
decision-making and taking-action are targeted. According to Nolte and Osborne (2013), 
people living beyond breast cancer must make day-to-day decisions in response to changes 
in their health condition; decision-making and taking-action skills can encourage them to 
actively monitor their health and then change their behaviour. The main goal of CBT in self-
management is to promote recipients’ level of activation and promote their confidence in 
managing their health condition (Hibbard et al., 2007). However, no trial measured 
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recipients’ activation level prior to the SMI; therefore, a link between SMI effects and positive 
behaviour changes remains unclear (Hibbard et.al, 2007). 
4.4 Education-delivering SMIs 
Consistent with Howell et al. (2017), the overall quality of education-delivering SMIs was 
high enough to help effective monitoring of recipients’ post-treatment health status. People 
living beyond cancer seem to agree that receiving information from healthcare professionals 
can facilitate decision-making to help them sustain positive self-management behaviours in 
the long run (Powers et al. 2017).  
People living beyond breast cancer often find themselves emotionally challenged (Stanton 
and Bower, 2015). From an education perspective, mindfulness might be an effective and 
practical approach for an ongoing self-management of emotional issues (Haller et al., 2017). 
Mindfulness can help emotionally challenged people living beyond breast cancer to redirect 
their attention to other aspects of the present moment (e.g. breathing, walking or 
environmental sounds), thus avoiding rumination (Haller et al., 2017). Mindfulness training is 
consistent with CBT in several ways (Baer, 2003), enabling non-judgmental observation for 
early signs of a problem, promoting active management and reducing avoidance. Moreover, 
the likely effects of mindfulness as part of SMIs on the HRQoL of recipients’ partners or 
family carers has been suggested as promoting relationship closeness and subsequent 
adjustment living beyond breast cancer (Carlson et al., 2013).  
4.5 SMIs: Is there scope for web-based delivery? 
With mixed evidence deriving from only two trials in this review, the true effectiveness of 
online SMIs remains unclear. Triberti et al. (2019) points out that one major advantage 
online SMIs is convenience for the recipient. Indeed, participants in two of the reviewed trials 
(Admiraal et al., 2017; Lee et al., 2014) found online delivery to be a particularly attractive 
feature compared to having to attend appointments in person, which might further underpin 
adjustment to a new reality that moves away from the clinical environment. Historically, web-
based solutions have been challenged by low technology literacy among recipients (often 
but not exclusively linked to older age) and lack of clarity around compliance with the 
intervention. Low adherence rates could well hinder delivery fidelity and subsequently 
adversely impact on the effectiveness of SMIs. Ugalde et al. (2017) claim that actual use of 
online SMIs largely depends on the recipient’s own attitude and motivation rather than on the 
SMI’s technical properties. However, certain technical properties (e.g. user friendliness, 
ability to personalise SMI content) can be measures to improve consistent, long-term 
engagement with the intervention. Concerns also exist that online delivery might put a barrier 
on the formation of a collaborative and interactive relationship between recipients and 
healthcare professionals (Foster et al., 2016), however frequency of SMI delivery that is 
tailored to recipients’ needs and boosted by using online, real-time calls/interaction with 
healthcare professionals might provide feasible solutions.  
4.6 Applying SMIs to match the post-treatment phase 
Aligning target outcomes of a SMI to post-treatment phases and associated deficits in health 
status can theoretically be linked to greater SMI effectiveness (Howell et al., 2017). For 
instance, participants in Admiraal et al.’s (2017) psychoeducation programme had finished 
treatment within the previous six months, but self-reports of emotional issues were 
infrequent, which might explain why the trial was unable to show any viable SMI 
effectiveness. Henselmans et al. (2010) report that many people living beyond breast cancer 
(36%) appear to experience no distress at all during the first six months after treatment 
completion, yet distress increases a year later. Perhaps, SMIs that allow multiple 
components to be delivered in a phased fashion over time and be tailored to key health 
status deficits at said time-points might be linked to greater effectiveness. Longitudinal 
observational studies to describe over-time changes among people living beyond breast 
cancer could establish the level of need and help inform these SMIs. 
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4.7 Review strengths and limitations 
Aside from a systematic approach to the search for and evaluation of available evidence, a 
strength of the present review is that it involved diverse, internationally tested self-
management programmes targeting the core self-management skills, while it holistically 
looked at all domains of HRQoL. However, there are also some limitations. This review 
considered the effects of SMIs on recipients’ HRQoL only, although evidence regarding 
other outcomes, such as cost-effectiveness, were not examined. Moreover, only articles 
published in English and only three of the major electronic databases were considered. 
Despite the small possibility that non-English publications or additional eligible trials were 
missed, this review was performed on a ‘rapid’ mode to allow for a timely and 
comprehensive critical evidence synthesis that could be of immediate use to clinicians, 
researchers and people living beyond cancer. 
5. Implications 
According to guidelines created by Runowicz et al. (2016), it is recommended that 
healthcare professionals offer self-management programmes to people living beyond breast 
cancer as an option for a proactive and supportive follow-up service, particularly where 
deficits in physical/functional well-being (and tentatively, emotional well-being) are 
experienced or anticipated. Attention to baseline activation levels and close follow-up may 
be needed to ensure engagement with and adherence to SMIs over time. Researchers are 
urged to consider discussion points outlined here to introduce methodological tweaks to the 
content of SMIs (e.g. use of all five core self-management skills in one SMI) and 
modes/timing/duration of delivery in order to ensure true alignment to recipients’ ever-
changing needs and adjustment challenges. Importantly, the authors wish to further bring 
SMIs to the attention of people living beyond breast cancer and their relatives to encourage 
them to seek information regarding availability, content and delivery options for SMIs 
according to their healthcare needs.  
6. Conclusions 
SMIs are potentially effective for supporting predominantly the physical/functional well-being 
of people after primary treatment for breast cancer, although effect sizes are small and 
inconsistent across HRQoL domains. However, the decision-making and taking-action skills 
delivered by SMIs are commensurate as both can help recipients to finish a behavioural 
change process. More rigorous development and testing is required, working together with 
people living with breast cancer from the early development stages or at the refinement 
phase for existing SMIs to ensure that SMIs ‘talk’ to likely recipients’ ‘activation’ and 
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Table 1. Search strategy and keywords used in the electronic database searches  
MEDLINE 
(select Ovid MEDLINE(R) 
1946 to November Week 4 
2019 database)  
1. Breast neoplasms OR (breast adj5 (cancer* or 
carcinoma* or tumour* or tumor* or neoplas*)).tw. 
2. (“Self management” or “self care” or “self-care” or “self-
management”).tw. 
3. Quality of life OR (“health related quality of life”).tw. 
4. Searches 1-3 were combined with AND  
EMBASE 
(select Embase 1996 to 
2019 Week 47 databases) 
1. Breast tumor OR (breast adj5 (cancer* or carcinoma*or 
tumour* or tumor* or neoplas*)).tw. 
2. Self care OR (“self-management” or “self management” 
or “self-care).tw. 
3. Health related quality of life OR quality of life 
4. Searches 1-3 were combined with AND  
CINAHL 1. (“Breast Neoplasms+”) 
2. (“Self Care+”) OR (“Self-Management”) 
3. ("Health and Life Quality+") OR ("Quality of Life+") OR 
(“Psychological Well-Being") 





Table 2. Characteristics of reviewed RCTs  
Author, year, origin  Admiraal et al. 
(2017), The 
Netherlands  
Beatty et al. 
(2010), 
Australia  
Chan et al. 
(2017), 
Singapore  
Hoffman et al. 
(2012), USA  
Kvale et al. 
(2016), USA  
Lahart et al. 
(2016), UK   
Lee et al. 
(2014), South 
Korea  
Rogers et al. 
(2015) USA  
Zick et al. 
(2016), USA  
Study design  
 
Two-arm RCT Two-arm RCT Two-arm RCT  Two-arm RCT  Two-arm RCT  Two-arm RCT  Two-arm RCT  Two-arm RCT  Three-arm RCT  




























Target sample sizea 
 
64 per arm  33 per arm  32 per arm  85 per arm  Not reported  40 per arm 29 per arm  97 per arm 100 per arm 
Control group  Care as usual Care as usual Booklet on 
cancer self-
management 
Care as usual 
while on wait-list 









Care as usual  






























telephone calls  
Self-guided 
exercise and 








































































































































SMI duration  
 
12 weeks  12 weeks  3 weeks  8 weeks 12 weeks   24 weeks  12 weeks  12 weeks  6 weeks  
Assessment points 
 
0, 6 and 12¶ 
weeks 
0, 12¶ and 24 
weeks 
0 and 8¶ weeks 0, 8 and 12¶ 
weeks 
0 and 12¶ 
weeks 
0 and 24¶ 
weeks 
0 and 12¶ 
weeks 
0, 12¶ and 24 
weeks 
0, 6¶ and 10 
weeks 






FACT-B  SF-36 FACT-B EORTC QLQ-
C30   
FACT-B   LTQL 
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Author, year, origin  Admiraal et al. 
(2017), The 
Netherlands  
Beatty et al. 
(2010), 
Australia  
Chan et al. 
(2017), 
Singapore  
Hoffman et al. 
(2012), USA  
Kvale et al. 
(2016), USA  
Lahart et al. 
(2016), UK   
Lee et al. 
(2014), South 
Korea  
Rogers et al. 
(2015) USA  
Zick et al. 
(2016), USA  
Physical well-beingb -0.33§^ 12w: -1.78^ 
24w: 0.14^ 






Emotional well-beingb 0.15^ 12w: -0.37^ 
24w: -1.51^ 






Social well-beingb 0.03^ 12w: -1.52^ 
24w: -0.05^ 








-0.18^  Domain not 
assessed 






Cognitive well-beingb 0.22^ 12w: 0.13^ 
24w: 0.59** 












Global HRQOLb -0.07^ 12w: -0.01^ 
24w: 0.14^ 
0.11^ 0.40*** Domain not 
assessed 








29/36   29/36 32/36 32/36 28/36     33/36 30/36 34/36     30/36 
Random sequence 
generation bias 
Low risk Low risk Low risk Low risk Low risk Low risk Low risk Low risk Low risk 
Allocation concealment 
bias 
Low risk Low risk Low risk Low risk Unclear risk Low risk Low risk Low risk Low risk 
Blinding of participants 
and personnel bias 
High risk High risk High risk Low risk Unclear risk High risk Low risk Low risk High risk 
Blinding to outcome 
assessment bias 
High risk High risk Unclear risk High risk High risk High risk High risk Unclear risk High risk 
Incomplete outcome 
data bias 
Low risk Low risk Low risk Low risk Low risk Low risk Low risk Low risk Low risk 
Selective reporting bias 
 
High risk Low risk Low risk Low risk Low risk Low risk Low risk Low risk Low risk 
aBased on a reported a priori power calculation. 
bCells report Cohen’s d and p-value of comparison test control v. intervention from baseline to post-intervention. 
cStandard deviation was not reported, therefore we were unable to calculate effect size d. 
dControl v. relaxing acupressure. 
eControl v. stimulating acupressure. 
Abbreviations: CBT - Cognitive Behavioural Therapy; EORTC-QLQ C30 - European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30; FACT-B - Functional 
Assessment of Cancer Therapy-Breast; HRQoL - Health-related quality of life; LTQL - Long-Term Quality of Life Instrument; SF-36 - 36-Item Short Form Health Survey; SMI - Self-management intervention;  
^p>0.05; *p<0.05; **p<0.01; ***p<0.001 
§A positive effect size indicates improvement in the mean scores of the experimental group relative to the control group. A negative effect size indicates deterioration in the mean scores of the experimental 
group relative to the control group. 
¶Primary end-point. 
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